Clinical Trial Update: Human Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating human mesenchymal stem cells for moderate to severe bronchopulmonary dysplasia (BPD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Human Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Children's Hospital of Chongqing Medical University | Conditions: Bronchopulmonary Dysplasia | Phase 2 | Status: UNKNOWN